Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art

L de Mestier, C Dromain, G d'Assignies… - Endocrine-related …, 2014 - erc.bioscientifica.com
Well-differentiated neuroendocrine tumors (NETs) are a group of heterogeneous rare
tumors. They are often slow-growing and patients can have very long survival, even at the …

Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges

JP Castano, A Sundin, HR Maecke, C Villabona… - Cancer and Metastasis …, 2014 - Springer
This paper summarizes the current understanding of the biology of somatostatin receptor
(sst), role of immunotherapy in neuroendocrine tumor (NET), new agents for PPRT, and …

Digestive well-differentiated grade 3 neuroendocrine tumors: current management and future directions

A Pellat, AS Cottereau, LJ Palmieri, P Soyer… - Cancers, 2021 - mdpi.com
Simple Summary We herein present the latest data on characteristics and therapeutic
management of gastro-entero-pancreatic well-differentiated neuroendocrine grade 3 tumors …

Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead

A Sundin, A Rockall - Neuroendocrinology, 2012 - karger.com
Abstract Background: Gastroenteropancreatic neuroendocrine tumors (NETs), a
heterogeneous family of tumors arising in a variety of anatomic sites, are generally well …

Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an …

R Garcia-Carbonero, R Garcia-Figueiras… - Cancer and Metastasis …, 2015 - Springer
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a family of neoplasms with
a complex spectrum of clinical behavior. Although generally more indolent than carcinomas …

Advances in the diagnosis and management of well-differentiated neuroendocrine neoplasms

J Hofland, G Kaltsas, WW de Herder - Endocrine Reviews, 2020 - academic.oup.com
Neuroendocrine neoplasms constitute a diverse group of tumors that derive from the
sensory and secretory neuroendocrine cells and predominantly arise within the pulmonary …

Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors

X Merino-Casabiel, J Aller, J Arbizu… - Clinical and …, 2018 - Springer
Purpose Gastroenteropancreatic neuroendocrine tumors are a heterogeneous group of low
incidence neoplasms characterized by a low proliferative activity and slow growth. Their …

Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome

F Panzuto, E Merola, M Rinzivillo, S Partelli… - Pancreas, 2014 - journals.lww.com
Objectives The objective of this study was to determine the impact of different metastatic
spread patterns on outcome in advanced digestive neuroendocrine tumors (NETs). Methods …

ENETS consensus guidelines for the standards of care in neuroendocrine tumors

M Pavel, WW de Herder - Neuroendocrinology, 2017 - karger.com
The landscape of treatment options in neuroendocrine tumors (NET) has changed in the last
5 years. Novel targeted drugs have been introduced and approved for distinct types of NET …

An update on the development of concepts, diagnostic criteria, and challenging issues for neuroendocrine neoplasms across different digestive organs

A Couvelard, J Cros - Virchows Archiv, 2022 - Springer
Digestive neuroendocrine neoplasms (NENs) are a group of heterogeneous neoplasms
found throughout the digestive tract, with different behaviour and genetic background. In the …